Genomic Study Urges Caution in Using Mutational Results from Single Cancer Biopsies to Guide Treatment | GenomeWeb

By Julia Karow

Tumors appear to be more heterogeneous than previously thought in terms of the mutations they carry, so relying on a single biopsy to make treatment decisions based on mutational analysis could be problematic, according to a team of researchers led by the Cancer Research UK London Research Institute.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.